Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Jointherapeutics S R L has a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently includes 1 pending office action. This action is assigned to 1 distinct examiner, OLSON, ANDREA STEFFEL, in 1 distinct art unit. The 1 pending office action represents the company's current focus in the Biotechnology & Pharmaceuticals sector.
OLSON, ANDREA STEFFEL is the busiest examiner, managing 1 pending office action. Because there is only 1 distinct examiner, the entire pending workload is concentrated with this individual. This single pending office action represents the company's current active prosecution within the 1 distinct art unit.
Practitioners should note that the 1 distinct examiner handles the entire pending inventory, allowing for a consistent prosecution path. The presence of 1 distinct art unit indicates that the company's current intellectual property efforts are concentrated in a specific technical field. This 1 pending office action serves as the sole active matter for the company within the Biotechnology & Pharmaceuticals technology area.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OLSON, ANDREA STEFFEL | 1 | 62.4% | -11.9% |
| Art Unit | Apps |
|---|---|
| 1693 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18560254 | MIXTURES OF POLYSACCHARIDES AND POLYAMINOSACCHARIDES WITH IMPROVED RHEOLOGICAL PROPERTIES | OLSON, ANDREA STEFFEL | 1693 | §103Other | Final Rejection | — | Pending | Nov 10, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialJointherapeutics S R L has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Andrea Steffel Olson has the most, with 1 of Jointherapeutics S R L's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
